What melatonin actually does
Melatonin is a timing hormone, not a sedative. Released by the pineal gland as light fails, it tells the brain "night has begun," lowering alertness temperature and opening the sleep gate. The NIH fact sheet frames supplemental melatonin's clearest wins around circadian timing — sleep-onset latency and rhythm disorders.
The dose paradox
Your body releases melatonin in fractions of a milligram. Classic dose-finding research found physiological doses — roughly 0.3 to 1 mg — effective for sleep onset, while higher doses produced no proportionally greater sleep and more next-day residue: grogginess, vivid dreams, that "melatonin hangover" people describe. A 2013 meta-analysis supported melatonin for primary sleep disorders with generally mild side effects, and retail surveys repeatedly find products dosed several times past physiological need, sometimes mislabeled.
The market went louder; the physiology never did.
What 0.9 mg buys you
- A circadian signal sized like your own biology's.
- Lower odds of morning fog and dream intensity.
- Room for the rest of a formula to matter — when melatonin isn't doing sledgehammer duty, calm-lane ingredients have actual work to do.
What it doesn't buy: sedation. Anyone expecting the heavy blanket of a 10 mg gummy will call 0.9 mg "weak." That's the design, not a defect.
Inside YU Sleep
The disclosed 0.9 mg is the formula's most defensible line, and the one ingredient whose dose you can verify against the research directly. Paired with tart cherry (a natural melatonin source) and B-vitamin cofactors, the timing lane is the formula's strongest shelf.
Practical read
If you're currently on high-dose melatonin and feel groggy, the low-dose direction is worth a professional conversation — transitions, not cold switches. And if you trial YU Sleep, judge it by sleep-onset ease and morning clarity, the two metrics low-dose melatonin actually moves.
References
- NIH Office of Dietary Supplements. Melatonin Fact Sheet. ods.od.nih.gov
- Ferracioli-Oda E, et al. PLoS One. 2013. PubMed 23691095